Evidence map›Paper›PMID 27901083›Full record

ArticleScientific reports2016

Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation.

Xuben Hou, David Rooklin, Hao Fang, Yingkai Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Review
  2. Reactivation ofInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. NAD-Driven Sirtuin Activation byInternational journal of molecular sciences · 2024
    Article
  19. Frontiers in pharmacology · 2024
    Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xuben HouDepartment of Medicinal Chemistry and Key Laboratory of Chemical Biology of Natural Products (MOE), School of Pharmacy, Shandong University, Jinan, Shandong, 250012, China.
David RooklinDepartment of Chemistry, New York University, New York, New York, 10003, United States.
Hao FangDepartment of Medicinal Chemistry and Key Laboratory of Chemical Biology of Natural Products (MOE), School of Pharmacy, Shandong University, Jinan, Shandong, 250012, China.
Yingkai ZhangDepartment of Chemistry, New York University, New York, New York, 10003, United States.

Funding

Computational Studies of Histone ModificationsR01GM079223 · NIGMS · NEW YORK UNIVERSITY · PI ZHANG, YINGKAI · 2007 to 2016
$2.4M
NIGMS NIH HHS R01 GM079223
6 · The paper itself

Abstract

Resveratrol is a natural compound found in red wine that has been suggested to exert its potential health benefit through the activation of SIRT1, a crucial member of the mammalian NAD

Indexed as

Molecular Dynamics SimulationProtein DomainsBinding SitesEnzyme ActivationHumansProtein BindingProtein StabilityResveratrolSirtuin 1StilbenesSubstrate SpecificityTumor Suppressor Protein p53ResveratrolSIRT1 protein, humanSirtuin 1StilbenesTumor Suppressor Protein p53

Identifiers

PMID27901083
PMCPMC5128864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.